Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02603133 · ClinicalTrials.gov registry record · NA
Web-based Implementation for the Science of Enhancing Resilience Study
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 2,650
- Enrollment target
NCT02603133: Completed NA study, sponsored by Stanford University.
NCT02603133 is a NA study that has completed, run by Stanford University. The registered enrollment target is 2,650 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02603133, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,650 participants
- Enrollment target
Study Summary
Resilience means a healthcare provider's ability to cope, recover, and learn from stressful events, as well as their access to resources that promote health and well-being. Neonatal intensive care unit (NICU) health professionals' need to have particularly good resilience, because their work is extremely stressful and their patients, fragile preterm infants, require their undivided attention. The investigators propose a feasible and engaging intervention to enhance resilience among NICU health professionals promoting their ability to provide safe care.
Primary Outcome
Burnout (emotional exhaustion) is the primary resilience outcome. The Maslach Burnout Inventory (MBI) has been the gold standard tool in the field of burnout research. In our investigations, the Emotional Exhaustion subscale, in particular, is consistently associated with variables such as staff turnover, disruptive behavior, productivity, delays, and teamwork. When used as a "percent agree" metric, we have shown it to be a very effective indicator of emotional exhaustion at the group level for
Interventions
- BEHAVIORAL Gratitude
- BEHAVIORAL Three Good Things
- BEHAVIORAL Random Acts of Kindess
- BEHAVIORAL Awe
- BEHAVIORAL 1 Good Chat
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,650 participants |
| Start Date | 2016-07 |
| Est. Completion | 2019-07 |
| Phase | NA |
What the finished NCT02603133 record still lists
NCT02603133 is an interventional study that assigns participants to a tested intervention. Its 2,650 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% higher).
The record links to 0 conditions, and to 5 interventions - of which Gratitude is the first listed.
NCT02603133 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02603133 about?
NCT02603133 is a clinical study titled "Web-based Implementation for the Science of Enhancing Resilience Study". Resilience means a healthcare provider's ability to cope, recover, and learn from stressful events, as well as their access to resources that promote health and well-being. Neonatal intensive care unit (NICU) health professionals' need to have particularly good resilience, because their work is extr...
What is the current status of trial NCT02603133?
This trial is currently completed. It is a NA study. The enrollment target is 2,650 participants. The study started on 2016-07. Estimated completion is 2019-07.
What interventions are being tested in trial NCT02603133?
The interventions under investigation include: Gratitude (BEHAVIORAL), Three Good Things (BEHAVIORAL), Random Acts of Kindess (BEHAVIORAL), Awe (BEHAVIORAL), 1 Good Chat (BEHAVIORAL).
Who is sponsoring clinical trial NCT02603133?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02603133's enrollment target sits among peer trials
2,650 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06825715 · 2,653 participants · NA
Multilevel Intervention for Precision Oncology
- NCT06455085 · 2,634 participants · NA
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
- NCT05471908 · 2,674 participants · NA
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
- NCT05111925 · 2,690 participants
Pre- and Post-neuromusculoskeletal Injury Risk Evaluation for Return-to-Duty Enhancement
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia